543500
EVOQ
Start SIP
Invest Now
Start SIP in EVOQ
Performance
- Low
- ₹3
- High
- ₹4
- 52 Week Low
- ₹2
- 52 Week High
- ₹8
- Open Price₹3
- Previous Close₹3
- Volume20,000
Investment Returns
- Over 1 Month + 9.03%
- Over 3 Month -10.26%
- Over 6 Month -33.21%
- Over 1 Year -57.21%
Smart Investing Starts Here Start SIP with Evoq Remedies for Steady Growth!
Evoq Remedies Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 98.8
- PEG Ratio
- -
- Market Cap Cr
- 9
- P/B Ratio
- 0.2
- Average True Range
- 0.21
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.1
- RSI
- 47.7
- MFI
- 55.91
Evoq Remedies Financials
Evoq Remedies Technicals
EMA & SMA
Current Price
₹3.50
+
0.16
(4.79%)
- Bearish Moving Average 8
- Bullish Moving Average 8
- 20 Day
- ₹3.37
- 50 Day
- ₹3.63
- 100 Day
- ₹3.92
- 200 Day
- ₹4.61
Resistance and Support
3.24
- R3 3.74
- R2 3.54
- R1 3.44
- S1 3.14
- S2 2.94
- S3 2.84
Evoq Remedies Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-10-10 | Quarterly Results | |
| 2025-05-06 | Preferential issue of shares | |
| 2025-04-29 | Others | Rs.0.00 to consider 1. Raising of funds upto Rs. 99.00 Crores by way of issue of Warrants. 2. Issuance of Equity shares other than cash through swap of shares. 3. Other business matters. (Revised) |
| 2025-04-10 | Audited Results | |
| 2024-05-27 | Audited Results |
Evoq Remedies F&O
About Evoq Remedies
- NSE Symbol
- EVOQ
- BSE Symbol
- 543500
- Managing Director
- Mr. Bhumishth Patel
- ISIN
- INE0JVD01011
Similar Stocks to Evoq Remedies
Evoq Remedies FAQs
Evoq Remedies share price is ₹3 As on 02 January, 2026 | 10:15
The Market Cap of Evoq Remedies is ₹8.7 Cr As on 02 January, 2026 | 10:15
The P/E ratio of Evoq Remedies is 98.8 As on 02 January, 2026 | 10:15
The PB ratio of Evoq Remedies is 0.2 As on 02 January, 2026 | 10:15
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.